Vivos Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
Vivos Therapeutics (NASDAQ:VVOS) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $0.3431, down 76.23% over the last 52-week period.
August 11, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vivos Therapeutics is expected to report an EPS of $-0.14 in its upcoming earnings release. The company's history of missing EPS estimates and subsequent share price drops could potentially impact the stock negatively.
Vivos Therapeutics has a history of missing EPS estimates, which has consistently led to drops in its share price. Given this trend and the analysts' estimate of a negative EPS for the upcoming quarter, it is likely that the stock price may experience a negative impact in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100